These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29932604)

  • 21. Schedules of controlled substances: temporary placement of three synthetic phenethylamines into Schedule I. Final order.
    Drug Enforcement Administration. Department of Justice
    Fed Regist; 2013 Nov; 78(221):68716-9. PubMed ID: 24236337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2013 May; 78(95):28735-9. PubMed ID: 23678676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB- CHMICA and MDMB-FUBINACA) Into Schedule I. Notice of Intent.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Dec; 81(245):93595-9. PubMed ID: 28068047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schedules of Controlled Substances: Placement of AH-7921 Into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Apr; 81(72):22023-5. PubMed ID: 27101639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schedules of Controlled Substances: Placement of MT-45 Into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice.
    Fed Regist; 2017 Dec; 82(238):58557-9. PubMed ID: 29235771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schedules of controlled substances: placement of perampanel into Schedule III. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2013 Dec; 78(231):72013-6. PubMed ID: 24294637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schedules of Controlled Substances: Placement of 10 Synthetic Cathinones Into Schedule I. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Mar; 82(39):12171-7. PubMed ID: 28355044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schedules of controlled substances: placement of suvorexant into Schedule IV. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Aug; 79(167):51243-7. PubMed ID: 25167596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schedules of Controlled Substances: Placement of Three Synthetic Phenethylamines Into Schedule I. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Sep; 81(187):66181-4. PubMed ID: 27726316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schedule of controlled substances: placement of tramadol into schedule IV. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Jul; 79(127):37623-30. PubMed ID: 25016619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schedules of Controlled Substances: Extension of Temporary Placement of Three Synthetic Phenethylamines in Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2015 Nov; 80(219):70657-9. PubMed ID: 26567439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schedules of Controlled Substances: Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA into Schedule I. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Sep; 81(172):61130-3. PubMed ID: 27632803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Aug; 79(163):49661-82. PubMed ID: 25167591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schedules of Controlled Substances: Placement of AB-CHMINACA, ABPINACA and THJ-2201 Into Schedule I. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Oct; 82(198):47971-4. PubMed ID: 29035496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2015 Nov; 80(218):69861-4. PubMed ID: 26567437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schedules of Controlled Substances: Placement of UR-144, XLR11, and AKB48 into Schedule I. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 May; 81(91):29142-5. PubMed ID: 27192731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schedules of controlled substances: temporary placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into Schedule I. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2003 Apr; 68(65):16427-30. PubMed ID: 12678045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schedules of Controlled Substances: Extension of Temporary Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA in Schedule I of the Controlled Substances Act. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Feb; 81(24):6175-7. PubMed ID: 26859904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2011 Oct; 76(204):65371-5. PubMed ID: 22016903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schedules of controlled substances: removal of naloxegol from control. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2015 Jan; 80(15):3468-70. PubMed ID: 25730920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.